NCT00054145View on ClinicalTrials.gov

Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

June 30, 2003

Primary Completion Date

April 30, 2007

Conditions

Breast Cancer

Interventions

DRUG

perifosine

Trial Locations (4)

L8V 5C2

Margaret and Charles Juravinski Cancer Centre, Hamilton

N6A 4L6

Cancer Care Ontario-London Regional Cancer Centre, London

K1H 1C4

Ottawa Regional Cancer Centre, Ottawa

M5G 2M9

Princess Margaret Hospital, Toronto

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

University Health Network, Toronto

OTHER

NCT00054145 - Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter